VERTIRON 25MG contains Cinnarizine which belongs to the group of medicines called antihistamines. It is indicated as a maintenance therapy for symptoms of cerebral circulatory disorders (such as dizziness, tinnitus (ringing in the ears), headache, loss of memory, irritability and lack of concentration), disorders of balance (such as vertigo (spinning sensation), dizziness, tinnitus, nystagmus, nausea or vomiting) or peripheral circulatory disorders (such as Raynaud’s phenomenon (reduced blood flow to the fingers), paraesthesia (numbness of hands and feet), cold extremities, nocturnal cramps, acrocyanosis, intermittent claudication, trophic disturbances, trophic and varicose ulcers). It can also be used in the prophylaxis of migraine and motion sickness.
Cinnarizine is a histamine H-1 receptor antagonist with muscarinic anticholinergic, sedative, anti-serotonergic and vasodilator properties. VERTIRON 25MG works by preventing the narrowing of blood vessels, leading to vasodilation and increased blood supply to the targeted organs. Try to take this medicine preferably after meals, as it may reduce the incidence of epigastric distress or gastric irritation. Avoid consumption of alcohol while taking this medicine, as it may increase the risk of side effects.
The most common side effects of this medicine are drowsiness, nausea and weight gain. Avoid traveling, driving or operating any tools or machines while you are feeling drowsy or sleepy. Contact your doctor if any of the symptom bothers you. Before taking this medicine, inform your doctor if you have any liver or kidney disease. VERTIRON 25MG is generally not recommended for use in pregnant or lactating women and children (under 12 years). Consult your doctor before taking.
Cinnarizine is a histamine H-1 receptor antagonist with muscarinic anticholinergic, sedative, anti-serotonergic and vasodilator properties. It works by inhibiting the contractions of vascular smooth muscle cells by blocking the activation of voltage-gated calcium channels, leading to vasodilatation of blood vessel and enhanced blood flow in condition such as Raynaud’s phenomenon, paraesthesia, nocturnal cramps, headache and varicose ulcers.
It also mediates neurotransmission in the central nervous system and provides relief from loss of memory, irritability and lack of concentration. It inhibits vestibular sensory nuclei in the inner ear and suppresses disorders of balance (such as vertigo, tinnitus, nystagmus). It also has muscarinic anticholinergic properties which helps to provide relief from motion sickness, nausea and vomiting.
Take VERTIRON 25MG as directed by your physician. It should be taken preferably after meals. Swallow the medicine as whole with a sip of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and health condition. Continue to take this medicine, as long as your doctor tells you to do so, to obtain better results.
Nausea:
Try taking this medicine with, or just after meals. Stick to simple meals. Do not eat rich or spicy food.
Weight gain:
Try to exercise more regularly, for e.g., by going for a daily walk or run.
Somnolence:
Try to rest and relax. Get enough sleep. Avoid traveling, driving or operating any tools or machines while you are feeling drowsy or sleepy. If the symptom still persists, contact your doctor for advice.
VERTIRON 25MG is considered safe for use by pregnant women. It is advised to consult your doctor before taking this medicine.
VERTIRON 25MG should be used with caution in breastfeeding mothers. Consult your doctor before taking this medicine.
Do not drive or operate any machines, because this medicine may cause somnolence especially at the start of treatment.
Avoid consumption of alcohol while taking this medicine.
VERTIRON 25MG should be taken with caution in patients with kidney problems. Consult your doctor for advice.
VERTIRON 25MG should be taken with caution in patients with liver problems. Consult your doctor for advice.
Do not take this medicine if you are allergic to cinnarizine.
Before taking VERTIRON 25MG, inform your doctor if you have:
Talk to your doctor, if you are taking,
Drug | : | Cinnarizine |
Pharmacological Category | : | Antihistamine, Antivertigo, Antiemetic |
Therapeutic Indication | : | Cerebral circulatory disorders, Peripheral circulatory disorders and Disorders of balance |
Dosage Forms | : | Tablet |
Store below 20-25°C and keep out of reach of children.
Is VERTIRON 25MG safe during lactation?
No. Do not take this medicine if you are breast-feeding due to lack of safety data. Consult your doctor for advice.
Can VERTIRON 25MG cause drowsiness?
Yes. The most common side effect of this medicine is drowsiness. Try to rest and relax. Get enough sleep. Avoid traveling, driving or operating any tools or machines while you are feeling drowsy or sleepy. If the symptom still persists, contact your doctor for advice.
Can we consume alcohol while taking VERTIRON 25MG?
No. Avoid consumption of alcohol while taking this medicine, as it may increase the risk of side effects.
1. KD. Tripathi. Histamine and Antihistaminics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 168.
2. KD. Tripathi. Antiemetic, Prokinetic and Digestant Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 663-664.
3. Medical Corps, Israel Defense Force. A Double-blind Comparison of Scopolamine with Cinnarizin for Prevention of Simulator Sickness. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on September 2010] [Accessed 30th December 2020] https://clinicaltrials.gov/ct2/show/NCT01198106
4. Milind Vasant Kirtane, Anita Bhandari, Prashant Narang and Ravi Santani. Cinnarizine: A Contemporary Review. NCBI; PMC US National Library of Medicine, National Institute of Health. April 2017. [Accessed 30th December 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6841794/
5. Foad Taghdiri, Mansoureh Togha, Soodeh Razeghi Jahromi and Farshid Refaeian. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. NCBI; PMC US National Library of Medicine, National Institute of Health. May 2014. [Accessed 30th December 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021030/
6. Aspin Pharma (Pvt) Ltd. Stugeron tablet/Stugeron forte capsule (cinnarizine). Aspin.com. [Revised on October 2017] [Accessed 30th December 2020] http://aspin.com.pk/wp-content/uploads/2020/02/Stugeron-PIL.pdf
7. Janssen-Cilag or Janssen Pharmaceutica NV. Health Products Regulatory Authority (HPRA). [Revised on November 2019] [Accessed 30th December 2020] http://www.hpra.ie/img/uploaded/swedocuments/311b29d1-75be-4d1e-8d70-dcbe034c2f03.pdf
8. Generics [UK] Limited and Gerard Laboratories. Electronic Medicines Compendium (EMC); [Revised on October 2014] [Accessed 30th December 2020] https://www.medicines.org.uk/emc/files/pil.2607.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.